跳至主要内容
临床试验/NCT05429749
NCT05429749招募中4 期

Intravenous Iron Supplement to Prevent Postoperative Delirium After Hip Fracture Surgery

Seoul National University Bundang Hospital1 个研究点 分布在 1 个国家目标入组 264 人开始时间: 2020年7月30日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
264
试验地点
1
主要终点
Postoperative delirium

研究概览

简要总结

This is a clinical trial to evaluate the effect of intravenous iron supplement with Ferinject (Ferric Carboxymaltose) in preventing postoperative delirium after hip fracture surgery.

详细描述

We hypothesized that IV iron supplement will (1) decrease postoperative delirium in hip fracture patients and (2) decrease the amount of transfusion and transfusion-related complications.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

入排标准

年龄范围
65 Years 至 —(Older Adult)
性别
All
接受健康志愿者

入选标准

  • femur neck fracture, intertrochanteric fractures
  • Iron deficiency anemia (Hb<12 in women, Hb<13 in men)
  • Iron deficiency (Serum ferritin <100ug/L or transferrin saturation<20%)
  • Who understands this clinical trial and volunteers and agrees to this trial

排除标准

  • Patient under the age of 65 years
  • Hb<7 or someone who has acute symptom of anemia(tachycardia, dyspnea, or dizziness)
  • High energy trauma
  • Preoperative delirium
  • Underlying disease which involves cognitive dysfunction (e.g. neurovascular diseases, acute myocardial infarction, pulmonary embolism)
  • Those who are inappropriate to participate in the clinical trial assessed by the investigators

研究组 & 干预措施

Ferinject group

Experimental

This group of hip fracture patients are treated with intravenous Ferinject between the admission and the surgery day.

干预措施: Ferinject (Drug)

Control group

Active Comparator

This group of hip fracture patients are treated with normal saline as a control group.

干预措施: Normal saline (Drug)

结局指标

主要结局

Postoperative delirium

时间窗: since immediately after the surgery to the discharge date

The presence and duration of postoperative delirium

次要结局

  • Functional outcomes(since immediately after the surgery to the discharge date)
  • Transfusion-related complications(since immediately after the surgery to the discharge date)
  • Hematologic outcomes(since immediately after the surgery to the discharge date)
  • Postoperative transfusion(Postoperative admission datessince immediately after the surgery to the discharge date)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Young-Kyun Lee

Professor

Seoul National University Bundang Hospital

研究点 (1)

Loading locations...

相似试验